Activity Info

Current dystrophin-targeted therapies have limitations, while emerging approaches are challenging expectations for what dystrophin restoration may achieve in Duchenne muscular dystrophy (DMD). Examine the relationship between dystrophin production, distribution, and clinical outcomes; consider the impact of progressive functional loss; and strengthen your interpretation of functional assessments and treatment goals. Then, explore the latest evidence and clinical trial results for current and emerging dystrophin-targeted therapies.